Clinical Trial

A Study for HSK47388 in Participants With Ulcerative Colitis

Name: A Study for HSK47388 in Participants With Ulcerative Colitis — clinical trial record (NCT07335055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-04.

Status change: Not Yet Recruiting → Recruiting 2026-03-03

Trial Details

NCT Number	NCT07335055
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd. Collaborators: Haisco-USA Pharmaceuticals, Inc.
Conditions	Ulcerative Colitis (UC)
Enrollment	150 participants
Start Date	2026-02-03
Primary Completion	2027-10-15 (estimated)
Study Completion	2029-02-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-05